— The patient lacked capacity in relation to treatment (because of an "inability to weigh and balance the impact of her ASD into the decision surrounding her treatment") and a trial of esketamine was not currently in her best interests.
Full details available at: https://www.mentalhealthlaw.co.uk/Barnet,_Enfield_and_Haringey_Mental_Health_NHS_Trust_v_CC_(2024)_EWCOP_65_(T3)?id=081124-2202